Castleview Partners, LLC Athira Pharma, Inc. Transaction History

Castleview Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$2.74 - $13.43 $29,792 - $146,024	-10,873 Reduced 99.03%	107 $0
Q2 2022 Aug 16, 2022	BUY	$2.74 - $13.43 $19,262 - $94,412	7,030 Added 177.97%	10,980 $33,000
Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $367 - $553	41 Added 1.05%	3,950 $53,000
Q4 2021 Feb 17, 2022	BUY	$9.17 - $16.39 $35,845 - $64,068	3,909 New	3,909 $50,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.